Learn / IRD
NASDAQ: IRD
Opus Genetics (IRD) stock, explained like you're 5
Opus Genetics trades on the Nasdaq under the ticker IRD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 387 million dollars.
- Ticker
- IRD
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 387 million dollars
Is Opus Genetics a small, medium or large cap company?
No. Opus Genetics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 387 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Opus Genetics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IRD stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Opus Genetics, Inc. (IRD) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- symbol__ Stock Quote Price and Forecast (CNN)
- Adults in a gene therapy trial saw vision gains through 24 months. Children improved through six months. (Stock Titan)
- Citizens reiterates Opus Genetics stock rating on cohort progress (Investing.com)
- Citizens reiterates Market Outperform rating on Opus Genetics, $17 price target (TradingView)
Follow IRD in your daily brief
Each trading day at 5 PM ET we post what happened to Opus Genetics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IRD
Questions about Opus Genetics stock
What does Opus Genetics do?
Opus Genetics trades on the Nasdaq under the ticker IRD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 387 million dollars.
What is the ticker symbol for Opus Genetics?
Opus Genetics trades under the ticker IRD on the Nasdaq.
What is Opus Genetics's market cap?
Opus Genetics is a small cap stock with a market cap of about 387 million dollars.
How does Opus Genetics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IRD stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IRD stock every day?
Add IRD to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.